1408 Non-canonical peptide sources broaden the landscape of targetable antigens in pancreatic cancer

• Philip D Greenberg,
• Eva K Verzani,
• Jennifer G Abelin,
• Alex M Jaeger,
• Tyler Jacks,
• Andrew J Aguirre,
• Susan Klaeger,
• Zackery A Ely,
• Zachary J Kulstad,
• Sudarsana Addepalli,
• Karl Clauser,
• Kevin S Kapner,
• Connor J Hennessey,
• Miles Agus,
• Jennifer Su,
• Steven Carr,
• William Freed-Pastor

Affiliations

Philip D Greenberg

5University of Washington School of Medicine, Seattle, WA, USA

Eva K Verzani

1The Broad Institute of MIT and Harvard, Cambridge, MA, USA

Jennifer G Abelin

1The Broad Institute of MIT and Harvard, Cambridge, MA, USA

Alex M Jaeger

5Moffitt Cancer Center, Tampa, FL, USA

Tyler Jacks

1Koch Institute at MIT, Cambridge, MA, USA

Andrew J Aguirre

2Dana-Farber Cancer Institute, Boston, MA, USA

Susan Klaeger

Genentech, South San Francisco, CA, USA

Zackery A Ely

1Koch Institute at MIT, Cambridge, MA, USA

Zachary J Kulstad

2Dana-Farber Cancer Institute, Boston, MA, USA

Sudarsana Addepalli

2Dana-Farber Cancer Institute, Boston, MA, USA

Karl Clauser

3Broad Institute, Cambridge, MA, USA

Kevin S Kapner

2Dana-Farber Cancer Institute, Boston, MA, USA

Connor J Hennessey

2Dana-Farber Cancer Institute, Boston, MA, USA

Miles Agus

1Koch Institute at MIT, Cambridge, MA, USA

Jennifer Su

1Koch Institute at MIT, Cambridge, MA, USA

Steven Carr

3Broad Institute, Cambridge, MA, USA

William Freed-Pastor

2Dana-Farber Cancer Institute, Boston, MA, USA